Monotherapy Study for Partial Seizures

Pfizer is sponsoring a clinical trial at the LSUHSCEpilepsyCenter in New Orleans where eligible candidates will be 18 years or older and experiencing partial epileptic seizures.  Those meeting the additional study criteria and willing to participate will receive one of two doses of the study drug for 20 weeks as treatment for their partial seizures. Study visits and study medication costs will be covered by the Sponsor. At the end of the study, there may be an option to extend treatment with the study drug for about 6 months.  Anyone interested in getting more detailed study information should e-mail the study coordinator at epicenter@lsuhsc.edu.  Please provide your name, e-mail address or telephone number and the study in which you are interested.